Sunshine Provision Retained In Opioids Bill Compromise
Executive Summary
Congressional negotiators knitting together US Senate and House versions of opioids legislation retained a “sunshine” provision opposed by industry that would expand the types of health-care professionals for whom device and drug manufacturers must report to the federal Open Payments database.